Bradley Foster & Sargent’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $485K | Buy |
6,938
+326
| +5% | +$22.8K | 0.01% | 389 |
|
2025
Q1 | $486K | Hold |
6,612
| – | – | 0.01% | 346 |
|
2024
Q4 | $433K | Hold |
6,612
| – | – | 0.01% | 375 |
|
2024
Q3 | $515K | Hold |
6,612
| – | – | 0.01% | 355 |
|
2024
Q2 | $516K | Sell |
6,612
-401
| -6% | -$31.3K | 0.01% | 350 |
|
2024
Q1 | $475K | Hold |
7,013
| – | – | 0.01% | 352 |
|
2023
Q4 | $472K | Sell |
7,013
-37,650
| -84% | -$2.54M | 0.01% | 352 |
|
2023
Q3 | $3.2M | Hold |
44,663
| – | – | 0.07% | 172 |
|
2023
Q2 | $3.2M | Buy |
44,663
+37,874
| +558% | +$2.71M | 0.07% | 172 |
|
2023
Q1 | $471K | Sell |
6,789
-4,502
| -40% | -$312K | 0.01% | 335 |
|
2022
Q4 | $766K | Hold |
11,291
| – | – | 0.02% | 276 |
|
2022
Q3 | $619K | Hold |
11,291
| – | – | 0.02% | 286 |
|
2022
Q2 | $746K | Buy |
11,291
+6,055
| +116% | +$400K | 0.02% | 267 |
|
2022
Q1 | $347K | Buy |
5,236
+669
| +15% | +$44.3K | 0.01% | 391 |
|
2021
Q4 | $266K | Sell |
4,567
-310
| -6% | -$18.1K | 0.01% | 403 |
|
2021
Q3 | $293K | Buy |
+4,877
| New | +$293K | 0.01% | 363 |
|